Degenerative Joint Disease clinical trials at UCSF

1 in progress, 0 open to eligible people

Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System
Sorry, not yet accepting patients
A Multi-Center Study in Patients Undergoing Total Hip Arthroplasty with the Smith+Nephew CATALYSTEM™ Primary Hip System. The purpose of the study is to assess safety and performance of the CATALYSTEM™ and to support product approval in global markets.
San Francisco, California and other locations

Our lead scientists for Degenerative Joint Disease research studies include Jeff Barry, MD.

Last updated: August 19, 2024

Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System